Kyle Hicok - R1 RCM Executive Officer
| RCMDelisted Stock | USD 14.31 0.01 0.07% |
Executive
Kyle Hicok is Executive Officer of R1 RCM Inc
| Age | 44 |
| Phone | 312-324-7820 |
| Web | https://www.r1rcm.com |
Kyle Hicok Latest Insider Activity
Tracking and analyzing the buying and selling activities of Kyle Hicok against R1 RCM stock is an integral part of due diligence when investing in R1 RCM. Kyle Hicok insider activity provides valuable insight into whether R1 RCM is net buyers or sellers over its current business cycle. Note, R1 RCM insiders must abide by specific rules, including filing SEC forms every time they buy or sell R1 RCM'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Kyle Hicok over six months ago Insider Trading |
R1 RCM Management Efficiency
The company has Return on Asset of 0.0235 % which means that on every $100 spent on assets, it made $0.0235 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.022) %, meaning that it generated no profit with money invested by stockholders. R1 RCM's management efficiency ratios could be used to measure how well R1 RCM manages its routine affairs as well as how well it operates its assets and liabilities.R1 RCM Inc has 1.74 B in debt with debt to equity (D/E) ratio of 0.69, which is OK given its current industry classification. R1 RCM Inc has a current ratio of 1.53, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for RCM to invest in growth at high rates of return.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Arlene Padron | Simulations Plus | N/A | |
| Tarah Bryan | Health Catalyst | N/A | |
| Katie Cook | Evolent Health | N/A | |
| Sarath Degala | Privia Health Group | N/A | |
| Scott Fenstermacher | HealthStream | 55 | |
| Daniel Orenstein | Health Catalyst | 54 | |
| William Moschella | Definitive Healthcare Corp | 48 | |
| Daniel LeSueur | Health Catalyst | 46 | |
| Mark Mannion | Evolent Health | N/A | |
| Jenny Harding | Privia Health Group | N/A | |
| Rebecca Adams | Forian Inc | N/A | |
| Ryan Barry | Health Catalyst | N/A | |
| Linda Llewelyn | Health Catalyst | 57 | |
| Michael JD | HealthStream | 48 | |
| Sheila MBA | Certara | N/A | |
| RN BSN | HealthStream | 48 | |
| Brad Bennion | HealthEquity | N/A | |
| Daniel Corcoran | Certara | N/A | |
| John MS | Simulations Plus | 44 | |
| John MD | Evolent Health | N/A | |
| Amanda Flanders | Health Catalyst | N/A | |
Management Performance
| Return On Equity | -0.022 | ||||
| Return On Asset | 0.0235 |
R1 RCM Inc Leadership Team
Elected by the shareholders, the R1 RCM's board of directors comprises two types of representatives: R1 RCM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RCM. The board's role is to monitor R1 RCM's management team and ensure that shareholders' interests are well served. R1 RCM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, R1 RCM's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sean Radcliffe, General VP | ||
| Pamela Spikner, Principal Officer | ||
| Atif Rahim, Sr Devel | ||
| Brian Gambs, EVP Officer | ||
| Joseph Flanagan, President CEO, Director | ||
| Kate Sanderson, Executive Officer | ||
| Evan CFA, Senior Relations | ||
| David Strickle, Executive Integration | ||
| Jennifer Williams, CFO VP | ||
| Gary Long, Executive Vice President Chief Commercial Officer | ||
| Jay Sreedharan, Chief Officer | ||
| Lee Rivas, CEO Director | ||
| Richard Evans, Corporate VP | ||
| Sean JD, General VP | ||
| Kyle Hicok, Executive Officer | ||
| Logan Johnston, Executive Management | ||
| Rachel Wilson, CFO VP | ||
| John Sparby, President | ||
| Corey Perman, Executive Risk |
RCM Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is R1 RCM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.022 | ||||
| Return On Asset | 0.0235 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 8.19 B | ||||
| Shares Outstanding | 422.39 M | ||||
| Shares Owned By Insiders | 1.04 % | ||||
| Shares Owned By Institutions | 86.91 % | ||||
| Number Of Shares Shorted | 10.81 M | ||||
| Price To Earning | 75.00 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in RCM Stock
If you are still planning to invest in R1 RCM Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the R1 RCM's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |